http://www.unboundmedicine.com/medline/ebm/research/DAUNOrubicin_citrate_liposomeUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19074216/full_citation/Phase_I_clinical_trial_of_liposomal_encapsulated_doxorubicin_citrate_and_docetaxel_associated_with_trastuzumab_as_neo_adjuvant_treatment_in_stages_II_and_IIIA_HER2_overexpressing_breast_cancer_patients__GEICAM_2003_03_study_Antón A, Ruiz A, Seguí MA, et al. 
Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. [JOURNAL ARTICLE]
Ann Oncol 2008 Dec 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17291237/full_citation/Liposome_encapsulated_doxorubicin_citrate_in_previously_treated_recurrent/metastatic_gynecological_malignancies_Angioli R, Palaia I, Calcagno M, et al. 
Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies. [Journal Article]
Int J Gynecol Cancer 2007 Jan-Feb; 17(1):88-93.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/16887094/full_citation/Remote_loading_of_doxorubicin_into_liposomes_driven_by_a_transmembrane_phosphate_gradient_Fritze A, Hens F, Kimpfler A, et al. 
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. [JOURNAL ARTICLE]
Biochim Biophys Acta 2006 Jun 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15878792/full_citation/Substantial_increases_in_idarubicin_plasma_concentration_by_liposome_encapsulation_mediates_improved_antitumor_activity_Dos Santos N, Waterhouse D, Masin D, et al. 
Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. [Journal Article]
J Control Release 2005 Jun 20; 105(1-2):89-105.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15813033/full_citation/[Influence_of_different_doxorubicin_salt_aggregates_on_the_leakage_of_liposomal_doxorubicin_in_vitro_and_long_circulation_in_vivo]Zhang L, Pan H, Liu M, et al. 
[Influence of different doxorubicin-salt aggregates on the leakage of liposomal doxorubicin in vitro and long circulation in vivo] [Journal Article]
Yao Xue Xue Bao 2004 Dec; 39(12):1018-22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15721372/full_citation/Entrapment_of_small_molecules_and_nucleic_acid_based_drugs_in_liposomes_Fenske DB, Cullis PR 
Entrapment of small molecules and nucleic acid-based drugs in liposomes. [Journal Article]
Methods Enzymol 2005.:7-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15717737/full_citation/Use_of_liposomal_anthracyclines_in_Kaposi's_sarcoma_Krown SE, Northfelt DW, Osoba D, et al. 
Use of liposomal anthracyclines in Kaposi's sarcoma. [Journal Article, Review]
Semin Oncol 2004 Dec; 31(6 Suppl 13):36-52.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15717735/full_citation/Advantages_of_liposomal_delivery_systems_for_anthracyclines_Allen TM, Martin FJ 
Advantages of liposomal delivery systems for anthracyclines. [Journal Article, Review]
Semin Oncol 2004 Dec; 31(6 Suppl 13):5-15.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/12634619/full_citation/Pharmacokinetics_of_doxorubicin_administered_i_v__as_Myocet__TLC_D_99;_liposome_encapsulated_doxorubicin_citrate__compared_with_conventional_doxorubicin_when_given_in_combination_with_cyclophosphamide_in_patients_with_metastatic_breast_cancer_Swenson CE, Bolcsak LE, Batist G, et al. 
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Anticancer Drugs 2003 Mar; 14(3):239-46.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/12472371/full_citation/Myocet__liposome_encapsulated_doxorubicin_citrate_:_a_new_approach_in_breast_cancer_therapy_Batist G, Barton J, Chaikin P, et al. 
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. [Journal Article, Review]
Expert Opin Pharmacother 2002 Dec; 3(12):1739-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles